A pharmaceutical composition for modifying a target structure, which includes at least one agent selected from the group consisting of energy modulation agents, plasmonics-active agents and combinations thereof; the energy modulation agents, when present, including one or more light emitters capable of emitting at least two different wavelengths of light, each wavelength of light associated with a different biological response, and the at least two different wavelengths capable of activating different biological responses; and a pharmaceutically acceptable carrier.

A pharmaceutical composition for modifying a target structure, which includes at least one agent selected from the group consisting of energy modulation agents, plasmonics-active agents and combinations thereof; the energy modulation agents, when present, including one or more light emitters capable of emitting at least two different wavelengths of light, each wavelength of light associated with a different biological response, and the at least two different wavelengths capable of activating different biological responses; and a pharmaceutically acceptable carrier.

A microwave source used in the radiotherapy device can be provided. The microwave source may include an anode block and one or more cathodes. The cathode of the microwave source may include a cathode support element having a plurality of slots. The plurality of slots can be axially around a circumference of the cathode support element. The microwave source may include a cathode heater including at least one filament. A first part of the at least one filament may be wound around the cathode support element along a first direction and received by a first portion of the plurality of slots, and a second part of the at least one filament may be wound around the cathode support element along a second direction and received by a second portion of the plurality of slots.

Headache treatment methods are described and include providing, an energy delivery device; locating a secondary or higher-order branch of a postganglionic nerve that provides innervation for a patient's head, by identifying a target region of the patient's head that includes the nerve branch; positioning, within the target region, a portion of the energy delivery device; and applying, from the positioned portion of the energy delivery device to the target region, an amount of energy effective to result in a stimulation activity of the nerve branch; and, after observing the stimulated nerve branch activity, delivering, from the energy delivery device to the nerve branch, energy in an amount effective to reduce a headache severity in the patient.

The presently disclosed subject matter is directed to a method of treating cancer, such as (but not limited to) metastatic bladder and breast cancer. The disclosed method comprises using two treatment modalities to synergistically treat primary and secondary tumor cells in a subject. The first element of the method comprises administering a therapeutically effective amount of a plasmonics-active metal nanoparticle to a subject comprising a primary cancer and a distant metastatic site, wherein the nanoparticle concentrates at the primary cancer. The method further comprises exposing the subject to photon radiation at the site of the primary cancer. The second element of the disclosed method comprises administering a therapeutically effective amount of an immune checkpoint modulator to the subject. The synergistic combination provides a rapid, safe, and effective treatment of local and distant lesions, better than each modality alone.

Embodiments provide for systems and methods for modulating activity of a live neuronal circuit within the brain of a mammal. In one example, a method comprises applying a focused microwave pulse to a focal spot corresponding to the live neuronal circuit, while simultaneously monitoring a brain image produced by a brain imaging system. In this way, the focused microwave pulse may be used to transiently modulate the function of the live neuronal circuit, as guided by anatomical and functional information provided via the brain imaging system, useful for both research purposes and for treating psychiatric, neurological and neuroendocrine disorders.

The present invention relates in a first aspect to an adhesion material for use in an individual containing encapsulated phase-change material. In particular, the adhesion material is for cosmetical or medicinal use in the body of an individual. The adhesion material contains encapsulated phase-change material having preferably a phase transition temperature above 40° C., like above 55° C. The adhesion material is particularly useful for adhering elements, like dental restorations, e.g. crowns or bridge, or brackets on elements in the body of an individual, like teeth or implants. That is, the adhesion material is particularly useful for adhering material in dental applications. In another aspect, a method is provided allowing removing a bracket, a crown or bridge, from implants, abutments or teeth. Furthermore, dental implant restoration systems and kits for permanent fixation of implants allowing improved removal thereof are provided.

The present invention relates in a first aspect to an adhesion material for use in an individual containing encapsulated phase-change material. In particular, the adhesion material is for cosmetical or medicinal use in the body of an individual. The adhesion material contains encapsulated phase-change material having preferably a phase transition temperature above 40° C., like above 55° C. The adhesion material is particularly useful for adhering elements, like dental restorations, e.g. crowns or bridge, or brackets on elements in the body of an individual, like teeth or implants. That is, the adhesion material is particularly useful for adhering material in dental applications. In another aspect, a method is provided allowing removing a bracket, a crown or bridge, from implants, abutments or teeth. Furthermore, dental implant restoration systems and kits for permanent fixation of implants allowing improved removal thereof are provided.

A subcutaneous implant, including: (a) a circuitry unit having a first end, a second end, a conducting lateral side, and an opposing lateral side; (b) a first electrode, disposed on an outer surface of the circuitry unit and laterally circumscribing the circuitry unit at the first end; (c) a second electrode, disposed on the outer surface of the circuitry unit and laterally circumscribing the circuitry unit at the second end; (d) circuitry, disposed within the circuitry unit, and configured to be wirelessly powered to drive an electrical current between the electrodes; and (e) an insulating member, disposed on the opposing lateral side such that, on the opposing lateral side, each electrode is sandwiched between the insulating member and the circuitry unit, and the insulating member inhibits electrical conduction from the electrodes into the tissue. Other embodiments are also described.

Methods, apparatuses and systems are provided for non-invasive delivery of microwave therapy. Microwave energy may be applied to epidermal, dermal and subdermal tissue of a patient to achieve various therapeutic and/or aesthetic results. In one embodiment, the microwave energy is applied to a target tissue via an energy delivery applicator connected to an energy generator. The energy delivery applicator may comprise one or more antennas, including monopole, dipole, slot and/or waveguide antennas (among others) that are used to direct the microwave energy to the target tissue. The energy delivery applicator may also comprise a cooling element for avoiding thermal destruction to non-target tissue and/or a suction device to localize thermal treatment at specific portions of a skin fold.